Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis
- PMID: 36403072
- PMCID: PMC9675963
- DOI: 10.1186/s13643-022-02123-y
Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis
Abstract
Background: Previous studies have investigated the prognostic value of the systemic immune-inflammation index (SII) in nasopharyngeal carcinoma (NPC). However, the results have been inconsistent. Therefore, this study aims to investigate the prognostic significance of SII in NPC through a meta-analysis.
Methods: The PubMed, Web of Science, Embase, and Cochrane Library databases were thoroughly searched. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to evaluate the prognostic value of the SII for survival outcomes.
Results: A total of six studies comprising 2169 patients were included in the meta-analysis. Pooled analyses indicated that a high SII was significantly associated with worse overall survival (OS) (HR = 1.69, 95% CI = 1.36-2.09, P < 0.001) and progression-free survival (PFS) (HR = 1.60, 95% CI = 1.29-1.98, P < 0.001) in patients with NPC. Subgroup analysis showed that SII was a significant prognostic marker for PFS but not for OS in NPC.
Conclusion: Our meta-analysis demonstrated that a high SII could be an efficient prognostic indicator of OS and PFS in NPC. In our opinion, SII could be used to predict long-term and short-term outcomes in patients with NPC. Furthermore, we suggest that SII be applied to help individual patients with NPC assess the prognostic risk.
Systematic review registration: PROSPERO CRD42022321570.
Keywords: Meta-analysis; Prognosis,·Nasopharyngeal carcinoma; Systemic immune-inflammation index.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory. Cancer Today. 2020; Available from: https://gco.iarc.fr/today.
-
- Tang LL, Huang CL, Zhang N, Jiang W, Wu YS, Huang SH, et al. Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial. Lancet Oncol. 2022;23(4):479–490. doi: 10.1016/S1470-2045(22)00058-4. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
